Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palbociclib Access Study in HR+/HER2- Advanced Breast Cancer
NCT02679755Phase 4Completed
- Sponsor
- Pfizer
- Start
- Mar 2016
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 4 trial of palbociclib in breast cancer, sponsored by Pfizer. Started Mar 2016; status: completed.
02
Drugs
palbociclib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02679755.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02679755.